121
Participants
Start Date
February 10, 2019
Primary Completion Date
February 17, 2020
Study Completion Date
March 5, 2020
metronidazole based quadriple therapy
patient randomized in QC will be treated by a double dose PPI (esomeprazole: 40 mg x 2 per day) in combination with amoxicillin (1 g x 2 per day), metronidazole (500 mg x 2 per day) and clarithromycin (500 mg x 2 per day)
placebo based quadriple therapy
patient randomized in TT will be treated by double dose PPI (esomeprazole: 40 mg x 2 per day) in combination with amoxicillin (1 g x 2 per day), clarithromycin (500 mg x 2 per day) and a placebo of metronidazole.
Fattouma Bourguiba Hospital, Monastir
mohamed bouchoucha
INDUSTRY